Lonza Group AG (LZAGF)
OTCMKTS · Delayed Price · Currency is USD
692.15
-13.55 (-1.92%)
Sep 12, 2025, 3:57 PM EDT
Lonza Group AG Market Cap
Lonza Group AG has a market cap or net worth of $48.25 billion as of September 12, 2025. Its market cap has increased by 1.93% in one year.
Market Cap
48.25B
Enterprise Value
52.97B
Revenue
8.92B
Ranking
n/a
PE Ratio
52.35
Stock Price
$692.15
Market Cap Chart
Since November 1, 1999, Lonza Group AG's market cap has increased from 3.78B to 48.25B, an increase of 1,176.70%. That is a compound annual growth rate of 10.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 49.28B | 15.49% |
| Dec 30, 2024 | 42.67B | 36.74% |
| Dec 29, 2023 | 31.20B | -14.17% |
| Dec 30, 2022 | 36.35B | -41.26% |
| Dec 30, 2021 | 61.89B | 29.41% |
| Dec 30, 2020 | 47.82B | 76.56% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 585.86M |
| CytoDyn | 424.27M |
| Northwest Biotherapeutics | 378.39M |
| American Oncology Network | 353.52M |